2019-10-28T10:44:47-05:00 2018-12-31 951777440 GREEN HASSON & JANKS LLP 10990 WILSHIRE BLVD 16TH FLOOR LOS ANGELES CA 900243929 990 2018-01-01 261636099 MELANOMA RESEARCH ALLIANCE FOUNDATION MELA 2023368935 1101 NEW YORK AVE NW NO 620 WASHINGTON DC 20005 MICHAEL KAPLAN PRESIDENT/CEO 2023368935 2019-10-22 1 LIZBETH G NEVAREZ P01399868 3108731600 38.186.35.254 2019-10-22 14:36:20 PD P DA39A3EE5E6B4B0D3255BFEF95601890AFD80709 1E5C2E37194314C3A47C760AEAFDC059525B6175 2018 2020-01-14 16:20:31Z MICHAEL KAPLAN 1101 NEW YORK AVE NW NO 620 WASHINGTON DC 20005 6435802 0 X WWW.MELANOMARESEARCHALLIANCE.ORG X 2007 DE TO ACCELERATE SCIENTIFIC DISCOVERY TO ELIMINATE SUFFERING AND DEATH DUE TO MELANOMA 23 22 13 50 0 4653 24404447 5541600 0 0 173572 367582 -57222 -64999 24520797 5844183 9161167 13770735 0 0 1412639 1588652 0 0 539851 1173152 1264467 11746958 16623854 12773839 -10779671 42426052 37272765 12059569 17748650 30366483 19524115 TO END SUFFERING AND DEATH DUE TO MELANOMA BY COLLABORATING WITH ALL STAKEHOLDERS TO ACCELERATE POWERFUL RESEARCH, ADVANCE CURES FOR ALL PATIENTS, AND PREVENT MORE MELANOMAS. 0 0 15743033 13770735 THE MELANOMA RESEARCH ALLIANCE FOUNDATION ("MRA") SUPPORTS AMBITIOUS AND INNOVATIVE PROJECTS, INITIATED BY INDIVIDUAL SCIENTISTS AND SCIENCE RESEARCH TEAMS, TO PREVENT, DETECT AND TREAT MELANOMA. MRA CONVENES A WORLD CLASS, CROSS-DISCIPLINARY GROUP OF EXPERT RESEARCHERS POSSESSING CLINICAL AND SCIENTIFIC EXPERTISE TO DEVELOP A RESEARCH AGENDA THAT WILL PROVIDE INNOVATIVE SOLUTIONS TO CRITICAL RESEARCH ISSUES LEADING TO BETTER TREATMENTS AND A CURE FOR MELANOMA. MRA MAKES GRANTS TO DOMESTIC AND FOREIGN RESEARCH UNIVERSITIES, MEDICAL SCHOOLS, AND NONPROFIT MEDICAL RESEARCH ORGANIZATIONS DIRECTLY INVOLVED IN DETERMINING THE CAUSES AND CURES OF MELANOMA ON THE CONDITION THAT SUCH RESEARCH BE MADE AVAILABLE TO THE SCIENTIFIC COMMUNITY. 15743033 1 1 0 1 0 0 0 0 0 0 1 0 0 0 1 0 1 0 0 0 1 1 0 0 1 0 0 1 0 1 0 0 0 0 0 0 0 0 1 0 0 0 0 1 0 0 0 1 X 13 0 1 13 1 1 1 0 0 0 0 1 1 0 0 0 0 0 0 X 23 22 1 0 0 0 0 0 0 1 0 0 0 1 1 1 1 1 1 1 0 0 AL AK AR CA CO CT DC FL GA HI IL KS KY ME MD MA MI MN MO NV NH NJ NM NY NC ND OH OK OR PA RI SC TN UT VA WA WV WI X X MICHAEL KAPLAN 2023368939 730 15TH ST NW 4TH FLOOR WASHINGTON DC 20005 DEBRA BLACK CHAIR/CO-FOUNDER 10.00 0.00 X X 0 0 0 LEON BLACK DIRECTOR/CO-FOUNDER 0.30 0.00 X 0 0 0 BEN BLACK DIRECTOR 0.30 0.00 X 0 0 0 MARIA BELL DIRECTOR 0.30 0.00 X 0 0 0 ELLEN DAVIS DIRECTOR 0.30 0.00 X 0 0 0 JASON FEDERICI DIRECTOR 0.30 0.00 X 0 0 0 JAMI GERTZ DIRECTOR 0.30 0.00 X 0 0 0 DAISY HELMAN DIRECTOR 0.30 0.00 X 0 0 0 SUSAN HESS DIRECTOR 0.30 0.00 X 0 0 0 MICHAEL KLOWDEN DIRECTOR 0.30 40.00 X 0 672741 34578 AMANDA ELLIAN DIRECTOR 0.30 0.00 X 0 0 0 NANCY MARKS DIRECTOR 0.30 0.00 X 0 0 0 MICHAEL MILKEN DIRECTOR 0.30 15.00 X 0 0 0 RICHARD RESSLER DIRECTOR 0.30 0.00 X 0 0 0 MARY JO ROGERS DIRECTOR 0.30 0.00 X 0 0 0 JEFFREY ROWBOTTOM DIRECTOR 0.30 0.00 X 0 0 0 ELLIOTT SIGAL DIRECTOR 0.30 0.00 X 0 0 0 GREGORY SIMON DIRECTOR 0.30 0.00 X 0 0 0 JONATHAN SIMONS DIRECTOR 0.30 0.00 X 0 0 0 JONATHAN SOKOLOFF DIRECTOR 0.30 0.00 X 0 0 0 ELIZABETH STANTON DIRECTOR 0.30 0.00 X 0 0 0 SUZANNE TOPALIAN DIRECTOR 5.00 0.00 X 0 0 0 MARGARET ANDERSON DIRECTOR/SECRETARY 0.50 0.00 X X 0 0 0 MICHAEL KAPLAN PRESIDENT & CEO 40.00 0.00 X 331744 0 21762 JOHN HUNTER TREASURER 10.00 40.00 X 0 380184 44491 KAMYAB HASHEMI NEJAD TREASURER (LEFT 3/15/18) 10.00 40.00 X 0 72963 6135 JOAN RUSSO CHIEF DEVELOPMENT OFFICER 40.00 0.00 X 220306 0 601 LOUISE PERKINS CHIEF SCIENCE OFFICER 40.00 0.00 X 214153 0 34547 KRISTEN MUELLER SCIENTIFIC PROGRAM DIRECTOR 40.00 0.00 X 137905 0 4353 CODY BARNETT DIRECTOR OF COMMUNICATIONS 40.00 0.00 X 103755 0 7401 1007863 1125888 153868 5 0 1 0 0 2103434 3438166 123689 5541600 369445 369445 407557 409420 -1863 -1863 -1863 117200 2103434 182199 -64999 -64999 5844183 0 0 302583 12095211 12095211 1675524 1675524 823113 502099 90543 230471 609089 371544 67000 170545 17036 10392 1874 4770 56960 34746 6265 15949 82454 50297 9070 23087 253 253 14700 14700 17907 17907 126595 103031 19533 4031 27121 19400 5253 2468 85611 61238 16582 7791 143493 98552 35770 9171 144917 88399 15941 40577 339836 304904 12598 22334 287859 273208 12927 1724 16891 12082 3272 1537 DUES & SUBSCRIPTIONS 20747 14841 4018 1888 STATE FILING FEES 12779 9141 2475 1163 RESEARCH MATERIALS 7387 5284 1431 672 18371 13140 3558 1673 16623854 15743033 340970 539851 6718915 5230737 13428469 14230225 18009454 13734662 75043 51403 101179 101179 0 0 4194171 4025738 42426052 37272765 137004 65314 11848581 17294177 57240 280000 16744 109159 12059569 17748650 X 12357029 5789453 18009454 13734662 30366483 19524115 42426052 37272765 X -10779671 -253488 190791 X 0 1 X 1 0 X X X 1 THE MILKEN INSTITUTE 954240775 7 1 13770735 0 1 13770735 0 1 0 0 0 0 1 0 0 0 0 0 0 0 0 0 1 0 PART IV, SECTION A, LINE 6: THE AMOUNT OF SUPPORT REPORTED TO MILKEN INSTITUTE REPRESENTS THE AMOUNT OF FUNDS THAT MRA PAYS DIRECTLY TO RESEARCH ORGANIZATIONS LISTED ON SCHEDULES F AND I THAT SUPPORT MELANOMA RESEARCH THAT ADVANCES THE MISSION OF BOTH MRA AND THE MILKEN INSTITUTE. MRA PROVIDES DIRECT SUPPORT TO PUBLIC CHARITIES AND EDUCATIONAL INSTITUTIONS FOR THE PURPOSES OF CANCER RESEARCH SPECIFICALLY RELATED TO MELANOMA. SUPPORTING THESE UNRELATED RESEARCH ORGANIZATIONS DIRECTLY SUPPORTS THE MISSION OF THE MILKEN INSTITUTE SINCE PART OF THE INSTITUTE'S MISSION IS TO IMPROVE HEALTH WORLDWIDE. BY MRA PROVIDING THE GRANTS DIRECTLY TO THE CHARITIES AND EDUCATIONAL INSTITUTIONS, IT FURTHER ASSISTS THE MILKEN INSTITUTE. BECAUSE THERE IS A DIRECT LINE OF COMMUNICATION BETWEEN DONOR AND GRANT RECIPIENT, THE INSTITUTE CAN RELY ON MRA TO PROVIDE GRANT MONITORING AND GRANT SUPPORT SERVICES TO GRANT RECIPIENTS. 2000 2000 16082003 16084003 954200 238550 0 0 649781 1000000 705026 954200 3309007 4963511 1000 1500 2000 2000 6500 162445 250000 176257 238550 827252 1240878 101179 101179 0 0 DUE TO AFFILIATE 109159 109159 5562604 -253488 -28091 -281579 5844183 0 5844183 16404972 -218882 -218882 16623854 0 16623854 PART XI, LINE 2D - OTHER ADJUSTMENTS: LOSS ON WRITE-OFF OF UNCOLLECTIBLE PLEDGES RECEIVABLE -28,091. PART XII, LINE 2D - OTHER ADJUSTMENTS: BAD DEBT EXPENSE 26,091. DISCOUNT ON GRANTS -58,630. GRANT FUNDS RETURNED -186,343. 1 EAST ASIA AND THE PACIFIC - AUSTRALIA, BRUNEI, BURMA, CAMBODIA, 0 0 GRANTS TO RECIPIENTS LOCATED IN THE REGION 778574 EUROPE (INCLUDING ICELAND & GREENLAND) - ALBANIA, ANDORRA, AUSTRIA, BELGIUM 0 0 GRANTS TO RECIPIENTS LOCATED IN THE REGION 671950 MIDDLE EAST AND NORTH AFRICA - ALGERIA, BAHRAIN, DJIBOUTI, EGYPT, 0 0 GRANTS TO RECIPIENTS LOCATED IN THE REGION 225000 0 0 0 0 0 0 1675524 0 1675524 EAST ASIA AND THE PACIFIC - AUSTRALIA, BRUNEI, BURMA, CAMBODIA, TEAM SCIENCE AWARD 778574 WIRE EUROPE (INCLUDING ICELAND & GREENLAND) - ALBANIA, ANDORRA, AUSTRIA, BELGIUM TEAM SCIENCE AWARD 446950 WIRE EUROPE (INCLUDING ICELAND & GREENLAND) - ALBANIA, ANDORRA, AUSTRIA, BELGIUM YOUNG INVESTIGATOR AWARD 225000 WIRE MIDDLE EAST AND NORTH AFRICA - ALGERIA, BAHRAIN, DJIBOUTI, EGYPT, YOUNG INVESTIGATOR AWARD 225000 WIRE 4 0 0 0 0 0 0 PART I, LINE 2: EACH PROPOSAL TO THE MRA IS REVIEWED FOR SCIENTIFIC MERIT AND TRANSLATIONAL AND CLINICAL IMPACT BY MRA'S WORLD-CLASS GRANT REVIEW COMMITTEE (GRC). CRITERIA ARE DESCRIBED IN THE MRA'S REQUEST FOR PROPOSALS. GRC MEMBERS ARE SENIOR THOUGHT-LEADERS IN MELANOMA AND CANCER RESEARCH. AFTER SCIENTIFIC PEER REVIEW BY THE GRC, THE MRA BOARD OF DIRECTORS APPROVES FINAL RESEARCH AWARDS FOR FUNDING. RESEARCH AWARD FUNDS ARE DISPENSED ON AN ANNUAL BASIS, CONTINGENT UPON MRA STAFF REVIEW OF ANNUAL PROGRESS REPORTS SUBMITTED BY THE GRANTEES. PART I, LINE 3: AWARDEES PROVIDE MRA WITH ANNUAL WRITTEN REPORTS OF THEIR RESEARCH PROGRESS AND COMPLIANCE WITH BUDGET GUIDELINES. FUNDS ARE DISTRIBUTED IN ANNUAL INSTALLMENTS AND NEXT YEAR'S INSTALLMENT IS NOT PROVIDED UNTIL SATISFACTORY REVIEW BY THE MRA CHIEF SCIENCE OFFICER AND SCIENTIFIC PROGRAM DIRECTOR. AWARDEES MUST KEEP SYSTEMATIC AND COMPLETE RECORDS ON THE RECEIPT AND DISBURSEMENT OF ALL AWARD FUNDS, AND MAY NOT COMMINGLE ANY FUNDS FROM OTHER SOURCES. LEVERAGED FINANCE FIGHTS MELANOMA 2220634 2103434 117200 8000 2570 129150 42479 2220634 2103434 117200 8000 2570 129150 42479 182199 -64999 1 DANA FARBER CANCER INSTITUTE 450 BROOKLINE AVE BP418 BOSTON MA 02215 042263040 501(C)(3) 1400000 2 TEAM SCIENCE AWARDS H LEE MOFFITT CANCER CENTER & RESEARCH INSTITUTE 12902 MAGNOLIA DRIVE TAMPA FL 33612 592451713 501(C)(3) 1125000 TEAM SCIENCE AWARD & YOUNG INVESTIGATOR AWARD THOMAS JEFFERSON UNIVERSITY 1020 WALNUT STREET PHILADELPHIA PA 19107 231352651 501(C)(3) 975000 TEAM SCIENCE AWARD & YOUNG INVESTIGATOR AWARD YALE UNIVERSITY 25 SCIENCE PARK 3RD FLOOR NEW HAVEN CT 06520 060646973 501(C)(3) 975000 TEAM SCIENCE AWARD & YOUNG INVESTIGATOR AWARD NEW YORK UNIVERSITY SCHOOL OF MEDICINE 545 FIRST AVENUE NEW YORK NY 10016 135562308 501(C)(3) 900000 TEAM SCIENCE AWARD THE REGENTS OF THE UNIVERSITY OF CALIFORNIA LOS ANGELES 10889 WILSHIRE BOULEVARD LOS ANGELES CA 90095 956006143 PUBLIC UNIVERSITY 900000 TEAM SCIENCE AWARD THE ROCKEFELLER UNIVERSITY 1230 YORK AVENUE NEW YORK NY 10065 131624158 501(C)(3) 900000 TEAM SCIENCE AWARD THE UNIVERSITY OF CHICAGO 5801 S ELLIS AVENUE CHICAGO IL 60637 362177139 501(C)(3) 675000 TEAM SCIENCE AWARD & YOUNG INVESTIGATOR AWARD UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER 1515 HOLCOMBE BOULEVARD HOUSTON TX 77030 746001118 PUBLIC UNIVERSITY 600000 2 YOUNG INVESTIGATOR AWARD & TEAM SCIENCE AWARD UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER 5323 HARRY HINES BLVD MC 9029 CAMBRIDGE MA 02139 756002868 PUBLIC UNIVERSITY 495369 TEAM SCIENCE AWARD MASSACHUSETTS INSTITUTE OF TECHNOLOGY - KOCH INSTITUTE FOR INTEGRATIVE CANC 77 MASSACHUSETTS AVENUE CAMBRIDGE MA 02139 042103594 501(C)(3) 450000 TEAM SCIENCE AWARD THE PENNSYLVANIA STATE UNIVERSITY COLLEGE OF MEDICINE 500 UNIVERSITY DRIVE HERSHEY PA 17033 246000376 PUBLIC UNIVERSITY 450000 TEAM SCIENCE AWARD UNIVERSITY OF MARYLAND BALTIMORE 220 ARCH STREET ROOM 02-148 BALTIMORE MD 21201 526002033 PUBLIC UNIVERSITY 450000 TEAM SCIENCE AWARD COLORADO STATE UNIVERSITY 555 SOUTH HOWES 6003 CAMPUS DELIVERY FORT COLLINS CO 80523 846000545 PUBLIC UNIVERSITY 225000 YOUNG INVESTIGATOR AWARD REGENTS OF THE UNIVERSITY OF MINNESOTA 2221 UNIVERSITY AVE SE STE 100 MINNEAPOLIS MN 55414 416007513 PUBLIC UNIVERSITY 225000 YOUNG INVESTIGATOR AWARD SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTE 120 THEORTY SUITE 200 IRVINE CA 92697 952226406 501(C)(3) 225000 YOUNG INVESTIGATOR AWARD THE RECTOR AND VISITORS OF THE UNIVERSITY OF VIRGINIA PO BOX 400195 CHARLOTESVILLE VA 22904 546001796 501(C)(3) 225000 YOUNG INVESTIGATOR AWARD THE REGENTS OF THE UNIVERSITY OF CALIFORNIA SAN FRANCISCO 1855 FOLSOM STREET BOX 0812 SAN FRANCISCO CA 94143 946036493 PUBLIC UNIVERSITY 225000 YOUNG INVESTIGATOR AWARD THE SALK INSTITUTE FOR BIOLOGICAL STUDIES 10010 N TORREY PINES ROAD LA JOLLA CA 92037 952160097 501(C)(3) 225000 YOUNG INVESTIGATOR AWARD EMORY UNIVERSITY 1599 CLIFTON RD 3RD FLOOR ATLANTA GA 30322 580566256 501(C)(3) 100000 PILOT AWARD SLOAN KETTERING INSTITUTE FOR CANCER RESEARCH 1275 YORK AVE NEW YORK NY 10065 131924236 501(C)(3) 100000 PILOT AWARD NORTHWESTERN UNIVERSITY - CHICAGO CAMPUS 633 CLARK STREET EVANSTON IL 60208 362167817 501(C)(3) 99842 PILOT AWARD JOAN & SANFORD I WEILL MEDICAL COLLEGE OF CORNELL UNIVERSITY 1300 YORK AVE NEW YORK NY 10065 131623978 501(C)(3) 75000 YOUNG INVESTIGATOR AWARD UNIVERSITY OF HOUSTON 5000 GULF FWY ROOM 109 HOUSTON TX 77204 746001399 PUBLIC UNIVERSITY 75000 YOUNG INVESTIGATOR AWARD 24 0 PART I, LINE 2: EACH PROPOSAL TO THE MRA IS REVIEWED FOR SCIENTIFIC MERIT AND TRANSLATIONAL AND CLINICAL IMPACT BY MRA'S WORLD-CLASS GRANT REVIEW COMMITTEE (GRC). CRITERIA ARE DESCRIBED IN THE MRA'S REQUEST FOR PROPOSALS. GRC MEMBERS ARE SENIOR THOUGHT-LEADERS IN MELANOMA AND CANCER RESEARCH. AFTER SCIENTIFIC PEER REVIEW BY THE GRC, THE MRA BOARD OF DIRECTORS APPROVES FINAL RESEARCH AWARDS FOR FUNDING. RESEARCH AWARD FUNDS ARE DISPENSED ON AN ANNUAL BASIS, CONTINGENT UPON MRA STAFF REVIEW OF ANNUAL PROGRESS REPORTS SUBMITTED BY THE GRANTEES. ALL MRA-FUNDED INVESTIGATORS AND THEIR INSTITUTIONS MUST AGREE TO PERFORM THE RESEARCH PROPOSAL IN FULL COMPLIANCE WITH ALL APPLICABLE LAWS AND REGULATIONS, THE TERMS AND CONDITIONS OF THE MRA REQUEST FOR PROPOSALS, THE REQUIREMENTS OF THE MRA TERMS AND CONDITIONS OF THE RESEARCH PROPOSAL. AT ANY TIME DURING THE AWARD PERIOD, AWARDEES MUST NOTIFY AND MRA MUST APPROVE ANY SIGNIFICANT CHANGES TO THE RESEARCH PROPOSAL INCLUDING RESEARCH PLAN, BUDGET, AND PERSONNEL. AWARDEES PROVIDE MRA WITH ANNUAL WRITTEN REPORTS OF THEIR RESEARCH PROGRESS AND COMPLIANCE WITH BUDGET GUIDELINES. FUNDS ARE DISTRIBUTED IN ANNUAL INSTALLMENTS AND NEXT YEAR'S INSTALLMENT IS NOT PROVIDED UNTIL SATISFACTORY REVIEW BY THE MRA CHIEF SCIENCE OFFICER AND SCIENTIFIC PROGRAM DIRECTOR. AWARDEES MUST KEEP SYSTEMATIC AND COMPLETE RECORDS ON THE RECEIPT AND DISBURSEMENT OF ALL AWARD FUNDS, AND MAY NOT CO-MINGLE ANY FUNDS FROM OTHER SOURCES. X X X 0 0 0 0 0 0 0 1 0 MICHAEL KLOWDEN DIRECTOR 0 516561 0 150000 0 6180 0 8100 0 26478 0 707319 0 0 MICHAEL KAPLAN PRESIDENT & CEO 311054 0 20000 0 690 0 8100 0 13662 0 353506 0 0 0 JOHN HUNTER TREASURER 0 328204 0 50000 0 1980 0 8100 0 36391 0 424675 0 0 JOAN RUSSO CHIEF DEVELOPMENT OFFICER 220000 0 0 0 306 0 0 0 601 0 220907 0 0 0 LOUISE PERKINS CHIEF SCIENCE OFFICER 198356 0 15000 0 797 0 8100 0 26447 0 248700 0 0 0 PART I, LINE 7 EMPLOYEES WERE ELIGIBLE TO RECEIVE PERFORMANCE-BASED BONUSES. X 3 115689 FAIR MARKET VALUE X GIFT BAGS 1 8000 FAIR MARKET VALUE 0 1 0 PART I, COLUMN (B): NONCASH DONATIONS ARE LISTED BY TOTAL NUMBER OF DONORS. FORM 990, PART V, LINE 2A THE ORGANIZATION DOES NOT ISSUE ANY W-2S FOR THEIR EMPLOYEES. THE SUPPORTED ORGANIZATION, THE MILKEN INSTITUTE, ISSUES ALL W-2S BUT EMPLOYEE COMPENSATION IS PAID BY THE MELANOMA RESEARCH ALLIANCE ITSELF. W-2S REPORTED ARE THOSE THAT ARE ISSUED BY MILKEN INSTITUTE ON BEHALF OF MRA. FORM 990, PART VI, SECTION A, LINE 2 DEBRA BLACK, LEON BLACK AND BEN BLACK HAVE A FAMILY RELATIONSHIP. DEBRA BLACK AND RICHARD RESSLER HAVE A FAMILY RELATIONSHIP. JAMI GERTZ AND DEBRA BLACK HAVE A FAMILY RELATIONSHIP. FORM 990, PART VI, SECTION A, LINE 8B THERE IS NO EXECUTIVE COMMITTEE DURING THE YEAR. FORM 990, PART VI, SECTION B, LINE 11B MRA'S CEO AND TREASURER REVIEW THE FORM 990. THE FINAL DRAFT IS MADE AVAILABLE ELECTRONICALLY TO ALL THE BOARD MEMBERS BEFORE THE CEO SIGNS THE DOCUMENT AND IT IS FILED WITH THE IRS. FORM 990, PART VI, SECTION B, LINE 12C AS STATED IN THE MRA BYLAWS, EACH DIRECTOR, TRUSTEE, PRINCIPAL OFFICER, AND MEMBER OF A COMMITTEE OF THE BOARD IS TO SIGN A STATEMENT ANNUALLY AFFIRMING THEY HAVE RECEIVED THE CONFLICT OF INTEREST POLICY, THEY HAVE READ AND UNDERSTAND IT, AND THEY AGREE TO COMPLY WITH IT. UPON POTENTIAL CONFLICT OF INTERESTS, THE BOARD OR COMMITTEE WILL RESOLVE THE CONFLICT IN THE BEST INTEREST OF THE ORGANIZATION. FORM 990, PART VI, SECTION B, LINE 15A ACCORDING TO THE MRA BYLAWS, MEMBERS OF THE BOARD REVIEW AND APPROVE THE MRA CEO SALARY TO ENSURE IT IS JUST AND REASONABLE. DURING THIS ANNUAL REVIEW, MEMBERS OF THE BOARD USE THE FEDERAL FORM 990 OF OTHER ORGANIZATIONS FOR COMPARABLES. THERE ARE NO OTHER OFFICERS, DIRECTORS, OR KEY EMPLOYEES THAT ARE COMPENSATED BY MRA. FORM 990, PART VI, SECTION C, LINE 19 THE ORGANIZATION MAKES ITS GOVERNING DOCUMENTS, CONFLICT OF INTEREST POLICY AND FINANCIAL STATEMENTS AVAILABLE TO THE PUBLIC UPON REQUEST. A COPY OF THE FORM 990 AND THE FINANCIAL STATEMENTS ARE AVAILABLE ON THE ORGANIZATION'S WEBSITE. FORM 990, PART XI, LINE 9: LOSS ON WRITE-OFF OF UNCOLLECTIBLE PLEDGES RECEIVABLE -28,091. BAD DEBT EXPENSE -26,091. DISCOUNT ON GRANTS 58,630. GRANT FUNDS RETURNED 186,343. MILKEN INSTITUTE 1250 FOURTH STREET SANTA MONICA CA 90401 954240775 EDUCATIONAL, ECONOMIC RESEARCH, HEALTHCARE RESEARCH CA 501(C)(3) LINE 7 N/A 0 0 0 0 0 0 0 0 0 0 0 1 0 1 0 0 1 0 0 0